The risk for COVID-19-related hospitalization was not significantly different between vaccinated older adults with vs without age-restrictive access to nirmatrelvir-ritonavir.

Using the COMPASS model, researchers project risk of cardiac late effects for survivors of pediatric ALL at age 50 years.

Donald Trump is losing ground with a key voting group, according to a new national tracking poll. The survey shows sharp ...

Attorney General planning to take legal action against Trump Administration for cutting Digital Equity Program funding that ...

A new study offers unprecedented insights into the incel (involuntary celibate) community, uncovering critical facts that ...

CHICAGO -- Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with ...